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ABSTRACT 1 
Photosensitizers belonging to the boron-dipyrromethenes (BODIPYs) class were recently found 2 
endowed with good efficacy in the antibacterial photodynamic therapy (aPDT) against both Gram-3 
positive and Gram-negative bacteria. In this paper, we report on the remarkable adjuvant effect 4 
exerted in this respect by linear polyamidoamines (PAAs), a family of moderately basic polymers 5 
obtained by Michael-type polyaddition of amines to bisacrylamides. Three different PAAs (AGMA1, 6 
BP-AGMA and BP-DMEDA) were studied, testing for each two different molecular weight samples 7 
(8.000 and 24.000 Da). At non-toxic concentrations (1 or 10 µg mL-1) all PAAs remarkably improved 8 
the killing efficacy of BODIPY upon irradiation with a green LED device (range: from 480 to 580 9 
nm with λmax = 525 nm) up to an energy rate of 16.6 J cm-2. A 6 – 7 log units decrease in bacteria 10 
survival was observed with concentrations of BODIPY of 1.0 µM and 0.1 µM in the case of 11 
Escherichia coli and Staphylococcus aureus, respectively. The one-way analysis of variance 12 
(ANOVA) was used to evaluate the statistical significance of different treatments (n ³ 3). Thus, the 13 
PAA-photosensitizer combination warrants potential as a new, effective and mild method of killing 14 
bacteria. Moreover, the antibacterial treatment here reported might be successfully applied to defeat 15 
the bacterial resistance often encountered with many antibacterial drugs owing to the double action 16 
of this two-components treatment. 17 
 18 
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Introduction 1 
The Photo-Dynamic chemo-Therapy (PDT) concerns the treatment of a localized pathology via the 2 
administration of a photosensitizer (PS), following irradiation of the diseased area with low energy 3 
electromagnetic field (i.e. visible light) [1]. 4 
In medicine, PDT is successfully applied for the treatment of several diseases such as localized 5 
cancers or precancerous malignancies, particularly those developed on the skin. However it finds 6 
application also in the treatment of localized infections occurring after cutaneous lesions arisen after 7 
burns or wounds or, even more, for the disinfection of dental channels [2]. 8 
Antibacterial PSs should exhibit one or more cationic groups on its frame, thus allowing an 9 
ionic interaction with the negatively charged bacterial outer envelope. To this aim, phenothiazines, 10 
cationic phthalocyanines, cationic porphyrins are the most frequently PSs reported in the literature 11 
[2, 3]. Together with the cationic moiety, it is known that the binding of PSs to microorganisms could 12 
be enhanced by the presence of a complementary moiety of the PS characterized by the presence of 13 
a neutral appendix penetrating the lipidic membrane; this effect is the so called “snorkel effect” [4]. 14 
In the last decade, a new class of dyes, the 4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes, 15 
entered the scenario of antibacterial PSs. These molecules, also known as boron-dipyrromethenes 16 
(BODIPYs), are easy synthesizable, versatile chromophores that have found application in different 17 
fields (mainly related to their fluorescent efficacy), such as DNA labelling, ion sensing, solar cells, 18 
and in light harvesting systems [5, 6]. BODIPYs could be used as photosensitizers in virtue of a 19 
structural modification aimed at inhibiting their strong fluorescence. This effect is generally obtained 20 
by the introduction of heavy atoms, such as iodine atoms, in the 2,6-pyrrole positions, as first reported 21 
by Nagano [7]. In previous works, we reported that a cationic BODIPY (2,6-diiodo-1,3,5,7-22 
tetramethyl-8-(N-methyl-4-pyridyl)-4,4’-difluoroboradiazaindacene (BOD-NMe) (Figure 1A) 23 
showed an interesting antimicrobial activity against Staphylococcus aureus, Escherichia coli and 24 
Pseudomonas aeruginosa biofilm [8, 9]. This molecule is characterized by a positively charged, 25 
methyl pyridinium substituent, in the meso position of the BODIPY skeleton. 26 
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The focus of many studies on antibacterial photodynamic therapy is addressed to improve the 1 
PS interaction to microorganisms by means of liposomes [10], quaternized chitosan hydrogels [11], 2 
auto-assembly PS-nanoparticles [12] and poly(lactic-co-glycolic) (PLGA) nanoparticles [13]. 3 
The aim of this study was to verify the possible role of cationic polyamidoamines (PAAs) as 4 
adjuvants in antimicrobial PDT (aPDT). PAAs are tert-amino polymers obtained by polyaddition of 5 
amines to bisacrylamides, which can be designed to be biocompatible and biodegradable [14]. 6 
Microbiological assays have been performed in order to investigate if three PAAs, characterized by 7 
two different molecular weight (8000 and 24000 Da), increased the photoinactivation rate of the 8 
BODIPY (BOD-NMe). 9 
Materials and Methods 10 
Photosensitizer and polymers  11 
2,6-Diiodo-1,3,5,7-tetramethyl-8-(N-benzyl-4-pyridyl)-4,4’-difluoroboradiazaindacene (BOD-N-12 
Me) (University of Insubria, Varese, Italy), the photosensitizer administered to photoinactivate 13 
bacteria, was synthesized according to a previously reported synthetic procedure [8]. A stock 1 mM 14 
(water:acetone-1:1) (sterilize water with a Direct-Q 3 UV with Pump of Millipore, Vimodrone (MI) 15 
Italy; acetone analytical grade by Sigma Aldrich, Milano, Italy) by solution was prepared as 16 
previously described [8] and diluted in Phosphate Buffer (PB) at pH 7.4 constituted of 17 
KH2PO4/K2HPO4 (Sigma Aldrich, Milano, Italy) 10 mM to the final chosen concentration (0.1 or 1 18 
µM). 19 
The Polyamidoamines (PAAs) tested, as potential adjuvant in antimicrobial PDT, are BP-20 
DMEDA, BP-AGMA and BP-DMEDA (University of Milan, Milan, Italy) and they were prepared 21 
according to a previously reported synthetic procedure [14]. They were fractionated by selective 22 
ultrafiltration on different membranes with cut-off, in the order, 100, 50, 20, 10 and 5 KDa (EMD 23 
Millipore Amicon™ Bioseparations Stirred Cells). For each sample, two fractions of average 24 
molecular weight 8000 and 24000 Da were selected for the biological tests. They corresponded 25 
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respectively, to the fraction retained between the 50- and 20 KDa and the fraction retained between 1 
10 and 5 KDa membranes. The actual number-average molecular weights (Mn) were determined by 2 
SEC-LALS [14]. Water stock solutions of PAA (1 mg mL-1) at two sizes, 8000 and 24000 Da, were 3 
administered to the cells at different final concentrations (1, 5 and 10 µg mL-1). 4 
Irradiation device 5 
The green LED array is composed of 12×3 W diodes distributed on an 11 cm diameter disk, and 6 
equipped with a heat sinker. The emitted light is characterized by a lambda max (λmax) at 525 nm 7 
(range: from 480 to 580 nm) (fluence rate 4.6 x 10-3 W cm-2, light energy density, or fluence, 4.14, 8 
8.28 and 16.56 J cm-2 for 15, 30 and 60 min of irradiation, respectively) and a width at half maximum 9 
of 50 nm. The electric supply was ensured by a 50 W current transformer. This array was placed above 10 
the plate at such a distance as to produce a homogeneous area of irradiation with a fluence rate of 11 
7.52×10-5 W cm-2 at 525 nm (l of maximum emission), as determined with a LI-1800 12 
spectroradiometer (LI-COR, Lincoln, Nebraska, USA). The green LED array, the heat sinker and the 13 
50 W current transformer were producted by Lomar Elettronica located in Flero (BS) Italy. 14 
Microorganisms 15 
Staphylococcus aureus ATCC 35033 was purchased from American Type Culture Collection 16 
(ATCC) (Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna, Brescia, 17 
Italy); Escherichia coli C1a [15] was obtained as a gift from University of Milan. They were chosen 18 
as Gram-positive and Gram-negative model microorganisms and were routinely grown in Luria-19 
Bertani (LB) (Sigma Aldrich, Milano, Italy) broth or on LB Agar plates (Sigma Aldrich, Milano, 20 
Italy) under aerobic conditions at 37°C. 21 
Photodynamic assays 22 
In order to rule out dark toxicity of PAAs, overnight cultures of the model microorganisms were 23 
diluted with PB to achieve a cell concentration equal to 108 CFU mL-1. The PAA solution was added 24 
to bacterial samples to obtain the chosen PAA concentration (1, 2.5, 5 or 10 µg ml-1) for both sizes 25 
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polymer (8.000 Da and 24.000 Da). The untreated and PAA treated samples were dark incubated at 1 
37 °C for 70 min and the cellular concentration was checked by a plate count technique and expressed 2 
as colony forming units (CFU mL-1).  3 
To induce photoinactivation, model microorganisms, grown overnight in LB and diluted to 4 
108 CFU mL-1, were treated with sub-optimal BOD-N-Me concentrations, 1 µM for E. coli and 0.1 5 
µM for S. aureus. PAAs were administered at 1 µg mL-1 for E. coli and 10 µg mL-1 for S. aureus. 6 
Bacteria were incubated 10 min in the dark and irradiated 15, 30 and 60 min under green LED device. 7 
In each experiment, the following controls were set up: a sample exposed to the photosensitizer and 8 
not irradiated (+PS, –light), a sample without the photosensitizer and not irradiated (–PS, –light), a 9 
sample without the photosensitizer and irradiated (–PS, +light), a sample exposed to PAAs and not 10 
irradiated (+PAA, -light), a sample exposed to PAA and irradiated (+PAA, +light). The PDT effect 11 
on cellular viability was evaluated after irradiation by means of a plate count technique and expressed 12 
as colony forming units (CFU mL-1).  13 
Statistical analysis 14 
The experiments were repeated at least three times on separate dates. Mean and SD calculations were 15 
performed using Microsoft Excel 2010. Data, normally distributed, were analysed by means of one-16 
way ANOVA (Origin_7.0 SR0; Origin lab, Origin Lab Corporation Northampton, Massachusetts, 17 
USA). Significant treatment effects were estimated (p < 0.05 and p < 0.01, 0.94 < 1 – β < 1). 18 
Results 19 
In the present PDT study, the improvement of the bacterial photoinduced inactivation exerted by the 20 
above cited BODIPY (Fig. 1A) in the presence of three different PAAs (Fig. 1B) has been evaluated. 21 
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BOD-NMe 
C19H19BF2I3N3 
Mw = 718.89 
A 
  
 
AGMA1 
Mw ~ 8000 
(~ 12 positive charges) 
Mw ~ 24000 
(~ 36 positive charges) 
BP-AGMA 
Mw ~ 8000 
(~ 40 positive charges) 
Mw ~ 24000 
(~ 120 positive charges) 
B 
BP-DMEDA 
Mw ~ 8000 
(~ 30 positive charges) 
Mw ~ 24000 
(~ 90 positive charges) 
Fig. 1 (A) Chemical structure, Molecular formula, and Molecular weight (Mw) of BOD-NMe. (B) 1 
Chemical structure of the repeating units of the three polymers with their molecular weight and the 2 
corresponding positive charges at pH = 7.2 3 
 4 
In the present context, the ideal antibacterial activity adjuvant should be intrinsically non-toxic 5 
to bacterial cells and insensitive to light. The PAA intrinsic toxicity was evaluated in the dark on 6 
Escherichia coli and Staphylococcus aureus. S. aureus was not sensitive to dark treatment of PAAs 7 
8000 and 24000 Da up to 10 µg mL-1, while E. coli was slightly sensitive to 2.5 and 5 µg mL-1 AGMA-8 
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1 and BP-DMEDA 24000 Da (Fig. 2). The slight decrease of one log unit of bacterial concentration 1 
was statistically significant: AGMA-1 24000 Da 2.5 and 5 µg mL-1 p = 0.049 (1 – β = 0.94) and p = 2 
0.033 (1 – β = 0.98), respectively; BP-DMEDA 24000 Da 2.5 and 5 µg mL-1 p = 0.002 (1 – β = 1) 3 
and p = 0.020 (1 – β = 0.99), respectively. 4 
 5 
Fig. 2 Effect of PAAs on Escherichia coli and Staphylococcus aureus. Bacteria were treated for 70 6 
min in the dark with increasing concentrations of cationic polymers with different Molecular Weight 7 
(Average Molecular Weight 8000 and 24000 Da). The bars represent bacterial concentrations 8 
expressed as CFU mL-1 of three biological replicates, whereas error bars represent the standard 9 
deviation from the mean, ** p ≤ 0.01, * p ≤ 0.05 (one-way ANOVA) 10 
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 1 
To photoinactivate bacteria the PS and PAA concentrations were established according to the 2 
sensitivity of the bacterial strain to both chemicals. Based on previous data [8], the experiments on 3 
E. coli and S. aureus were carried out using 1.0 µM and 0.1 µM BOD-NMe concentrations, 4 
respectively. These PS concentrations induced a decrease of 3 – 4 log units of a 108 CFU mL-1 5 
bacterial samples after 60 min irradiation with the green LED. The non-toxic concentrations of the 6 
PAAs used in the photodynamic experiments, were 1.0 µg mL-1 for E. coli and 10 µg mL-1 for S. 7 
aureus (Fig. 3). As expected, when PAAs were administered alone, the irradiation of cells did not 8 
influence bacterial viability (data not shown). 9 
In all PDT-experiments, the bacteria were incubated 10 min in the dark and then irradiated for 10 
15-30-60 min. As previously reported, this incubation time is sufficient to ensure the interaction 11 
between PS and bacteria and the amount of light irradiated is non-toxic to bacteria albeit suitable to 12 
activate the photoinduced killing effect of the BODIPY [8]. 13 
10 
 
 1 
Fig. 3 Effect of PAAs on BODIPY induced photoinactivation on E. coli (A,B,C) and S. aureus 2 
(D,E,F). Bacteria were incubated in the dark for 10 min with BOD-N-Me 1 µM and 0.1 µM, 3 
respectively. Bacterial samples were added or not with PAAs 1 µg mL-1 and 10 µg mL-1, respectively. 4 
Upon irradiation with increasing doses of light (joule cm-2) cellular viability (CFU mL-1) was 5 
checked. PDT experiments were performed at least three times. The black squares represent the effect 6 
of irradiation of cell culture alone (control), the red dots the effect of the PS alone under irradiation; 7 
blue triangles represent PS plus PAA (8000 Da) and overturned green triangles represent PS plus 8 
PAA (24000 Da). The PAA used in each experiment is indicated on the top of the figure. 9 
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 1 
The administered PAAs influenced the photoactivity of BOD-NMe on the two different model 2 
microorganisms depending on the PAA size and PAA type, however the killing effect was increased 3 
or equal to that obtained with photosensitizer alone (Fig. 3). 4 
In order to avoid any toxic effect in E. coli, PAAs have been administered at a very low 5 
concentration, 1 µg mL-1. The co-administration of AGMA-1 8000 Da and BOD-N-Me caused a 3 6 
log units viability decrease respect with BODIPY alone at the highest energy density tested. Thus the 7 
observed increase was energy-dose dependent. On the other hand, the AGMA-1 24000 did not cause 8 
any activity enhancement. The second PAA tested (BP-AGMA) showed a lower coadjutant effect as 9 
only a decrease of 2 log units was observed as compared with PS alone, whereas the last PAA tested 10 
(BP-DMEDA) did not produce any difference in the bacterial survival with respect to the effect of 11 
the only PS. 12 
PAAs have been administered to S. aureus at 10 µg mL-1, a concentration higher than that used 13 
in E. coli. Both sizes of AGMA-1, BP-AGMA and BP-DMEDA (8000 and 24000 Da) enhanced the 14 
photokilling activity of the BODIPY alone in S. aureus. In particular AGMA-1 8000 and BP-15 
DMEDA 8000 were more efficient than corresponding PAA 24000 Da at the half total irradiation 16 
time (30 min, 8.3 J cm-2): AGMA1 and BP-DMEDA 8000 Da determined a decrease of survivors of 17 
about 5 log units (Fig. 3D and 3F). When the PAAs 24000 Da were administered, similar decreases 18 
were not observed. BP-AGMA 8000 and 24000 Da caused a 3 log units decrease at 30 min of 19 
irradiation (Fig. 3E).  20 
Discussion 21 
The PAAs tested in this work are characterized by different chemical structures consistent with the 22 
reactants used in the synthesis. Two of them (BP-DMEDA and BP-AGMA) derived from the 23 
polyaddition of dimethylethylendiamine and 4-aminobutylguanidine, respectively, to 1,4-bis 24 
acryloylpiperazine (BP). The third one derived from the polyaddition of 4-aminobutylguanidine 25 
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(agmatine) to 2,2-bisacrylamidoacetic acid (BAC). Obviously, these three PAAs have different ionic 1 
properties, therefore, they were differently charged in aqueous media. At the pH of the experiments 2 
(pH = 7.2), the number of charges for 8000 Da and 24000 Da polymers respectively were: AGMA1 3 
12 and 36; BP-AGMA 40 and 120; BP-DMEDA 30 and 90 [16]. Moreover, AGMA1 was not purely 4 
basic. It was amphoteric, but prevailingly basic. Hence, the figure 1 represents the excess positive 5 
charges. 6 
As far as the toxicity of PAA against the two tested bacterial strains is concerned, it is interesting 7 
to observe that E. coli was slightly more sensitive to PAA than S. aureus. Actually, up to 10 µg mL-8 
1 concentration, none of the tested PAAs showed intrinsic toxicity in S. aureus. 9 
Although the toxicity of these PAA was quite low against E. coli it was statistically significant upon 10 
treatment with AGMA1 and BP-DMEDA at 24000 Da at 2.5 and 5 µg mL-1, respectively. The toxicity 11 
does not seem to correlate with the number of the positive charges, however it is noticeable that a 12 
slightly higher toxicity was observed in the case of the high molecular weight AGMA1 and BP-13 
DMEDA.  14 
It was considered that the studies concerning the adjutant effect of the PAAs on the 15 
photoinduced cell killing by BODIPY could be carried out, in principle, under two possible conditions 16 
concerning the PAA concentration: a) by using a partially toxic concentration; b) by using a non-17 
toxic concentration. In the first option, a low synergistic effect between PS and PAA could be masked 18 
by the killing effect of the single substances and, therefore, difficult to be observed or properly 19 
evaluated. On the other hand, the use of non-toxic PAA concentration would allow the clear detection 20 
of whichever possible enhanced photodynamic activity, therefore this latter experimental condition 21 
has been chosen. 22 
When the PS-PAA mixtures were used against E. coli and S. aureus, the highest killing rate 23 
effect was observed for the lower molecular weight fraction of AGMA1.  24 
As the killing effect is certainly related to the amount of PS inside or attached to the bacteria 25 
envelope, this result seems to indicate a higher availability of the photosensitizer in the bacterium 26 
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environment, probably due to an increased interaction of the PS with the cell wall and/or a higher PS 1 
permeability, elicited by the presence of PAA. 2 
The coadjutant effect of the higher Mw polymers (24000 Da) was less pronounced in all 3 
experiments carried out with both the microorganisms, but especially with the Gram-negative one. It 4 
is difficult to give an explanation to this result at this level of the scientific investigation. Actually an 5 
opposite result was expected with the larger polymers as higher positive charges density should 6 
increase the “detergent” effect, just like partially observed when the PAAs were tested against E. coli. 7 
Moreover, when the photoinduced killing effect of BOD-NMe was also considered, the higher 8 
molecular weight PAAs seems to decrease the enhancement of PS activation. We believed that a 9 
possible explanation could be found by considering the interaction of the 24000 Da samples with the 10 
external bacterium wall, thus masking the bacteria outer wall with a positively charged barrier. This 11 
barrier, conversely from the bacteria external negative charges, bears cationic groups thus repelling 12 
the equally charged PS or competing for the PS binding sites. 13 
By concluding in this work, it was for the first time demonstrated the enhancing effect of PAAs 14 
in the BODIPY photoinduced bacteria killing. The combined effect of PAA, PS and light afforded to 15 
kill both S. aureus and E. coli. This excellent result could have been obtained after only one hour 16 
irradiation with a harmless green light in the presence of a very low concentration of a cationic 17 
BODIPY, i.e. 1.0 µM and 0.1 µM for E.coli and S. aureus, respectively. 18 
Despite of it has been already proved that BOD-NMe can be considered a powerful antibacterial 19 
photosensitizer, the present work demonstrated that, in the presence of cationic polyamidoamine, the 20 
efficacy of BOD-NMe is remarkably further enhanced. This effect was particularly striking against 21 
the Gram-negative strain E. coli, which is usually more tolerant to photoinactivation with respect to 22 
the Gram-positive bacteria [17]. 23 
The three PAAs used in this study have never been tested before as antibacterial cationic 24 
polymers. Two of these (AGMA-1 and BP-DMEDA) showed a certain degree of intrinsic toxicity 25 
against the Gram-negative bacterium tested (E. coli), however this effect is negligible at 26 
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concentrations < 5 µg mL-1. Conversely, it was ineffective against Gram-positive S. aureus at all 1 
tested concentrations, suggesting a selective toxicity that could be exploited. Due to the presence of 2 
two components with different mechanism of action, the PDT conditions reported here open a new 3 
strategy towards the eradication of microorganisms, in localized and light accessible infections, since 4 
it could hardly elicit the selection of resistant bacterial strains. 5 
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